Exane Derivatives’s Ansys ANSS Stock Holding History

Exane Derivatives’s Portfolio ANSS Stock Details ANSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.68K	Sell	7 -705	-99%	-$187K	﹤0.01%	457
2022 Q1	$226K	Sell	712 -81	-10%	-$26.5K	0.06%	301
2021 Q4	$318K	Buy	793 +791	+39,550%	+$304K	0.08%	258
2021 Q3	$681	Hold	2	–	–	﹤0.01%	904
2021 Q2	$703	Hold	2	–	–	﹤0.01%	912
2021 Q1	$679	Hold	2	–	–	﹤0.01%	767
2020 Q4	$728	Sell	2 -248	-99%	-$83K	﹤0.01%	704
2020 Q3	$81.8K	Hold	250	–	–	0.02%	334
2020 Q2	$72.9K	Hold	250	–	–	0.02%	326
2020 Q1	$58.1K	Hold	250	–	–	0.02%	344
2019 Q4	$66.1K	Sell	250 -4,793	-95%	-$1.13M	0.01%	347
2019 Q3	$1.12M	Sell	5,043 -2,223	-31%	-$468K	0.2%	101
2019 Q2	$1.49M	Sell	7,266 -4,622	-39%	-$881K	0.26%	78
2019 Q1	$2.17M	Sell	11,888 -4,303	-27%	-$728K	0.43%	67
2018 Q4	$2.31M	Buy	16,191 +1,659	+11%	+$258K	0.42%	72
2018 Q3	$2.71M	Buy	14,532 +961	+7%	+$172K	0.51%	64
2018 Q2	$2.36M	Buy	13,571 +1,696	+14%	+$282K	0.39%	51
2018 Q1	$1.84M	Buy	11,875 +2,952	+33%	+$472K	0.37%	75
2017 Q4	$1.32M	Buy	+8,923	New	+$1.26M	0.23%	81

Other funds holding ANSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Exane Derivatives's ANSS Position: Q2 2022 in Review

Exane Derivatives reduced its Ansys (ANSS) stake by 99% in Q2 2022, selling an estimated $187K and leaving 7 shares worth $1.68K. The position accounts for ﹤0.01% of the portfolio, ranked #457.

Exane Derivatives first reported a position in ANSS in Q4 2017 and has held it in 19 quarters since. The position peaked at $2.71M in Q3 2018. 739 funds tracked by Wall St. Rank hold ANSS as of Q2 2022.

Exane Derivatives held 7 shares of Ansys worth $1.68K as of Q2 2022.
Exane Derivatives sold 705 Ansys shares in Q2 2022, an estimated $187K.
Ansys made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #457 holding.
Exane Derivatives first reported a position in Ansys in Q4 2017 and has held it in 19 quarters since.
Exane Derivatives's Ansys position peaked at $2.71M in Q3 2018.
739 funds tracked by Wall St. Rank held Ansys as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.